Spots Global Cancer Trial Database for methylprednisolone
Every month we try and update this database with for methylprednisolone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | NCT00002785 | Leukemia | filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine mesna methotrexate methylprednisol... pegaspargase prednisone therapeutic hyd... vincristine sul... allogeneic bone... low-LET cobalt-... low-LET photon ... | - 1 Year | Children's Oncology Group | |
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
| Phase II Study of Simvastatin for Relapsed/Refractory Myeloma | NCT01332617 | Myeloma | Simvastatin,Zol... | 18 Years - | University of Louisville | |
| Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00004192 | Lymphoma Neutropenia | filgrastim pegfilgrastim cisplatin cytarabine etoposide methylprednisol... | 18 Years - 120 Years | University of Nebraska | |
| Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma | NCT01621880 | Nasopharyngeal ... Adverse Effect ... Brain Necrosis | bevacizumab Corticosteroid | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
| L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | NCT02631109 | Hemophagocytic ... | Pegaspargase doxorubicin etoposide methylprednisol... | 14 Years - 75 Years | Beijing Friendship Hospital | |
| Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma | NCT00574288 | Multiple Myelom... | Part 1: Daratum... Part 2: Daratum... Methylprednisol... Dexamethasone | 18 Years - | Janssen Research & Development, LLC | |
| Combination Chemotherapy in Treating Patients With Lymphoma | NCT00002835 | Lymphoma | Bleomycin Sulfa... Filgrastim (G-C... Recombinant Int... Carmustine Cisplatin (CDDP... Cyclophosphamid... Cytarabine (ARA... Etoposide (VP-1... Idarubicin Ifosfamide Leucovorin Calc... Melphalan Methotrexate Methylprednisol... mitoxantrone hy... Vincristine Sul... Peripheral Bloo... Radiation Thera... | 15 Years - 59 Years | M.D. Anderson Cancer Center | |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | NCT00003661 | Graft Versus Ho... Leukemia Lymphoma Myelodysplastic... Neuroblastoma | anti-thymocyte ... busulfan cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - 54 Years | Roswell Park Cancer Institute | |
| Morton's Neuroma: Manipulation Versus Steroid Injection | NCT05707572 | Morton Neuroma | methylprednisol... manual manipula... | 18 Years - | Dundee Podiatry Clinic | |
| Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. | NCT04519476 | Refractory Mult... | Selinexor Lenalidomide Methylprednisol... | 18 Years - | Oncotherapeutics | |
| Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis | NCT04438382 | Hematopoietic a... Malignant Solid... Steroid-Refract... | Infliximab Intravenous Imm... Prednisone Methylprednisol... | 18 Years - | Eastern Cooperative Oncology Group | |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases | NCT00003662 | Graft Versus Ho... Leukemia Myelodysplastic... Thymic Carcinom... | anti-thymocyte ... busulfan cyclophosphamid... cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - | Roswell Park Cancer Institute | |
| Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation | NCT00005641 | Chronic Myelopr... Graft Versus Ho... Leukemia Multiple Myelom... Myelodysplastic... | anti-thymocyte ... busulfan cyclophosphamid... cyclosporine leucovorin calc... methotrexate methylprednisol... allogeneic bone... in vitro-treate... radiation thera... | 15 Years - 60 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma | NCT06209606 | Multiple Myelom... | Ruxolitinib Ora... Lenalidomide Methylprednisol... | 18 Years - | Oncotherapeutics | |
| Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | NCT00002471 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... methotrexate methylprednisol... therapeutic hyd... thiotepa vincristine sul... | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm | NCT04216524 | Blastic Plasmac... | Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Mercaptopurine Methotrexate Methylprednisol... Prednisone Rituximab Tagraxofusp-erz... Venetoclax Vincristine | 18 Years - | M.D. Anderson Cancer Center | |
| Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL | NCT00732498 | Lymphoma | Methylprednisol... Etoposide Cytarabine Cisplatin Rituximab In-Zevalin Y-Zevalin | 18 Years - | University of Arizona | |
| Corticosteroids for Cancer Pain | NCT00676936 | Cancer Pain | Methylprednisol... Placebo | 18 Years - | Norwegian University of Science and Technology | |
| Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma | NCT01621880 | Nasopharyngeal ... Adverse Effect ... Brain Necrosis | bevacizumab Corticosteroid | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | NCT04666129 | Metastatic Cast... Metastatic Cast... Non-Metastatic ... | Relugolix Abiraterone Prednisone Methylprednisol... Apalutamide Docetaxel | 18 Years - | Sumitomo Pharma Switzerland GmbH | |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | NCT00003661 | Graft Versus Ho... Leukemia Lymphoma Myelodysplastic... Neuroblastoma | anti-thymocyte ... busulfan cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - 54 Years | Roswell Park Cancer Institute | |
| Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP | NCT05280873 | Pneumonitis Malignant Tumor | Pirfenidone, me... Methylprednisol... | 18 Years - 75 Years | Guangzhou Institute of Respiratory Disease | |
| Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00557193 | Acute Lymphobla... Acute Undiffere... Childhood T Acu... | Asparaginase Biospecimen Col... Bone Marrow Bio... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Echocardiograph... Etoposide Filgrastim Laboratory Biom... Lestaurtinib Leucovorin Calc... Mercaptopurine Methotrexate Methylprednisol... Multigated Acqu... Pegaspargase Pharmacological... Prednisone Therapeutic Hyd... Vincristine Sul... | - 1 Year | Children's Oncology Group | |
| Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | NCT01181258 | Non-Hodgkin Lym... Chronic Lymphoc... | Rituximab Interleukin-2 Natural killer ... Cyclophosphamid... Methylprednisol... Fludarabine | - | Masonic Cancer Center, University of Minnesota | |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
| Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene | NCT01875237 | Leukemia Myeloma Myeloproliferat... | Fludarabine Melphalan Alemtuzumab Stem Cell infus... Tacrolimus Mini Methotrexa... G-CSF Donor Lymphocyt... AP1903 Methylprednisol... Questionnaire | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) | NCT03390387 | Childhood Acute... | Dexamethasone c... Dexamethasone i... Dexamethasone Methylprednisol... Daunorubicin Idarubicin Bortezomib Second phase of... Standard induct... Standard consol... | 1 Year - 50 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Methylprednisolone N Acetylcysteine in Hepatic Resections | NCT01726465 | Ischemic Reperf... Insufficiency; ... Liver Tumour | Methylprednisol... N-acetylcystein... | 18 Years - 70 Years | Istituto Clinico Humanitas | |
| 131MIBG to Treat Malignant Pheochromocytoma | NCT00028106 | Pheochromocytom... | [131]I-MIBG 6-[18F]Fluorodo... [123]I-MIBG | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia | NCT00022126 | Leukemia | asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate methylprednisol... pegaspargase thioguanine vincristine sul... allogeneic bone... radiation thera... | - 1 Year | Children's Oncology Group | |
| Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00004192 | Lymphoma Neutropenia | filgrastim pegfilgrastim cisplatin cytarabine etoposide methylprednisol... | 18 Years - 120 Years | University of Nebraska | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | NCT02166463 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Childhood Hodgk... Classic Hodgkin... | Bleomycin Sulfa... Brentuximab Ved... Cyclophosphamid... Doxorubicin Hyd... Etoposide Laboratory Biom... Methylprednisol... Pharmacological... Prednisone Quality-of-Life... Questionnaire A... Vincristine Sul... | 2 Years - 22 Years | National Cancer Institute (NCI) | |
| Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma | NCT05303792 | B Acute Lymphob... B Lymphoblastic... | Cyclophosphamid... Vincristine Dexamethasone Inotuzumab Ozog... Methotrexate Cytarabine Methylprednisol... Rituximab Prednisone Mercaptopurine Doxorubicin | 50 Years - | Alliance for Clinical Trials in Oncology | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia | NCT00002831 | Leukemia | Filgrastim Busulfan Cyclophosphamid... Cyclosporine Decitabine (DAC... Methotrexate Methylprednisol... Tacrolimus Allogeneic Bone... Peripheral Bloo... | 15 Years - 55 Years | M.D. Anderson Cancer Center | |
| Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma | NCT06209606 | Multiple Myelom... | Ruxolitinib Ora... Lenalidomide Methylprednisol... | 18 Years - | Oncotherapeutics | |
| A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma | NCT06356571 | Plasma Cell Mye... | Isatuximab SC-O... Montelukast Dexamethasone Acetaminophen Diphenhydramine Methylprednisol... Carfilzomib | 18 Years - | Sanofi | |
| Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | NCT00436761 | Unspecified Chi... | anti-thymocyte ... graft-versus-tu... sargramostim busulfan cyclosporine melphalan methylprednisol... flow cytometry immunologic tec... laboratory biom... allogeneic hema... umbilical cord ... | - 21 Years | National Cancer Institute (NCI) | |
| Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer | NCT01789892 | Lung Cancer | methylprednisol... fludeoxyglucose... positron emissi... computed tomogr... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy | NCT00312520 | Hemangiomas | prednisolone methylprednisol... | 1 Month - 4 Months | The Hospital for Sick Children | |
| Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant | NCT00376480 | Leukemia Myelodysplastic... | anti-thymocyte ... peripheral bloo... fludarabine pho... methylprednisol... thiotepa allogeneic hema... in vitro-treate... total-body irra... | - 50 Years | Dana-Farber Cancer Institute | |
| Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma | NCT05303792 | B Acute Lymphob... B Lymphoblastic... | Cyclophosphamid... Vincristine Dexamethasone Inotuzumab Ozog... Methotrexate Cytarabine Methylprednisol... Rituximab Prednisone Mercaptopurine Doxorubicin | 50 Years - | Alliance for Clinical Trials in Oncology | |
| Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant | NCT00376480 | Leukemia Myelodysplastic... | anti-thymocyte ... peripheral bloo... fludarabine pho... methylprednisol... thiotepa allogeneic hema... in vitro-treate... total-body irra... | - 50 Years | Dana-Farber Cancer Institute | |
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
| Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 | NCT02887976 | Prostate Cancer | SoluMatrix™ Abi... Methylprednisol... | 18 Years - | GU Research Network, LLC | |
| Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse | NCT00069966 | Lymphoma | filgrastim rituximab cisplatin cytarabine methylprednisol... pixantrone dima... autologous bone... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Bone Marrow Transplantation in Treating Patients With Leukemia | NCT00006451 | Graft Versus Ho... Leukemia Lymphoma | anti-thymocyte ... cyclophosphamid... cyclosporine methotrexate methylprednisol... allogeneic bone... in vitro-treate... radiation thera... | - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00720109 | Acute Lymphobla... Adult B Acute L... Childhood B Acu... | Asparaginase Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Etoposide Filgrastim Hydrocortisone ... Ifosfamide Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Methylprednisol... Pegaspargase Prednisone Radiation Thera... Vincristine Sul... | 2 Years - 30 Years | National Cancer Institute (NCI) | |
| Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen | NCT02199041 | Hematological M... | Cyclophosphamid... Thiotepa Fludarabine Melphalan Mesna G-CSF Mycophenolate m... Tacrolimus Methylprednisol... Total lymphoid ... Lymphocyte infu... CliniMACS | - 21 Years | St. Jude Children's Research Hospital | |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome | NCT01624805 | Aplastic Anemia de Novo Myelody... Myelodysplastic... Previously Trea... | Anti-Thymocyte ... Cyclosporine Filgrastim Methylprednisol... Pegfilgrastim | 18 Years - | M.D. Anderson Cancer Center | |
| Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome | NCT02462252 | Aplastic Anemia Hypoplastic Mye... | BL-8040 horse anti-thym... Methylprednisol... Cyclosporine | 18 Years - | BioLineRx, Ltd. | |
| Morton's Neuroma: Manipulation Versus Steroid Injection | NCT05707572 | Morton Neuroma | methylprednisol... manual manipula... | 18 Years - | Dundee Podiatry Clinic | |
| Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma | NCT02293109 | Contiguous Stag... Noncontiguous S... Stage I Adult L... Stage III Adult... Stage IV Adult ... Untreated Adult... | carfilzomib cyclophosphamid... vincristine sul... doxorubicin hyd... dexamethasone methotrexate cytarabine leucovorin calc... methylprednisol... rituximab laboratory biom... | 18 Years - 64 Years | University of California, Davis | |
| Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01005758 | Leukemia | cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera... | 18 Years - 50 Years | National Cancer Institute (NCI) | |
| Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | NCT03913559 | Acute Lymphobla... | Inotuzumab ozog... Methotrexate Hydrocortisone Cytarabine Diphenhydramine Acetaminophen Methylprednisol... | - 21 Years | St. Jude Children's Research Hospital | |
| Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | NCT01181258 | Non-Hodgkin Lym... Chronic Lymphoc... | Rituximab Interleukin-2 Natural killer ... Cyclophosphamid... Methylprednisol... Fludarabine | - | Masonic Cancer Center, University of Minnesota | |
| Morton's Neuroma: Manipulation Versus Steroid Injection | NCT05707572 | Morton Neuroma | methylprednisol... manual manipula... | 18 Years - | Dundee Podiatry Clinic | |
| Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | NCT00609739 | Leukemia | cyclosporine cytarabine filgrastim methotrexate methylprednisol... mitoxantrone hy... allogeneic bone... umbilical cord ... Cis-Retinoic ac... | - 18 Years | Masonic Cancer Center, University of Minnesota | |
| Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome | NCT00806598 | Myelodysplastic... Aplastic Anemia | Thymoglobulin Cyclosporine Methylprednisol... G-CSF | 15 Years - | M.D. Anderson Cancer Center | |
| A Trial of Selinexor, Ruxolitinib and Methylprednisolone | NCT06225310 | Multiple Myelom... Multiple Myelom... | Selinexor Ruxolitinib Methylprednisol... | - | Oncotherapeutics | |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome | NCT01624805 | Aplastic Anemia de Novo Myelody... Myelodysplastic... Previously Trea... | Anti-Thymocyte ... Cyclosporine Filgrastim Methylprednisol... Pegfilgrastim | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | NCT04666129 | Metastatic Cast... Metastatic Cast... Non-Metastatic ... | Relugolix Abiraterone Prednisone Methylprednisol... Apalutamide Docetaxel | 18 Years - | Sumitomo Pharma Switzerland GmbH | |
| An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy | NCT05350384 | Purtscher Retin... Pancreatic Canc... | Methylprednisol... | - | University of Catania | |
| Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia | NCT01670812 | Chronic Lymphoc... | FFP+HDMP+Rituxi... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery | NCT00438087 | Facial Palsy | methylprednisol... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients | NCT02944045 | Pneumocystis Steroids Immunocompromis... Hematologic Neo... Immunosuppressi... Neoplasms | Methylprednisol... Placebo | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
| Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer | NCT03661567 | Non-small Cell ... | chest radiation concurrent chem... Methylprednisol... | 18 Years - 75 Years | Sun Yat-sen University | |
| Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma | NCT00002599 | Multiple Myelom... | filgrastim recombinant int... sargramostim carmustine cyclophosphamid... doxorubicin hyd... melphalan methylprednisol... prednisone vincristine sul... low-LET cobalt-... low-LET photon ... | - 64 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | NCT00003728 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisolone therapeutic hyd... thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo... | - 17 Years | National Cancer Institute (NCI) | |
| Phase II Study of Simvastatin for Relapsed/Refractory Myeloma | NCT01332617 | Myeloma | Simvastatin,Zol... | 18 Years - | University of Louisville | |
| Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia | NCT00792948 | Acute Lymphobla... Adult B Acute L... Adult B Acute L... Adult L1 Acute ... Adult L2 Acute ... Adult T Acute L... Recurrent Adult... | Allogeneic Hema... Cyclophosphamid... Cytarabine Dasatinib Dexamethasone Doxorubicin Hyd... Etoposide Filgrastim Laboratory Biom... Leucovorin Calc... Methotrexate Methylprednisol... Peripheral Bloo... Prednisone Sirolimus Tacrolimus Total-Body Irra... Vincristine Sul... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors | NCT04151082 | Cranial Nerve D... Head and Neck C... Oropharyngeal C... | Methylprednisol... Prednisone Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer | NCT03661567 | Non-small Cell ... | chest radiation concurrent chem... Methylprednisol... | 18 Years - 75 Years | Sun Yat-sen University | |
| Morton's Neuroma: Manipulation Versus Steroid Injection | NCT05707572 | Morton Neuroma | methylprednisol... manual manipula... | 18 Years - | Dundee Podiatry Clinic | |
| Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | NCT00609739 | Leukemia | cyclosporine cytarabine filgrastim methotrexate methylprednisol... mitoxantrone hy... allogeneic bone... umbilical cord ... Cis-Retinoic ac... | - 18 Years | Masonic Cancer Center, University of Minnesota | |
| Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) | NCT02464657 | Leukemia Acute Myeloid L... Myelodysplastic... | Nivolumab Idarubicin Cytarabine Solu-medrol Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis | NCT04532736 | Nasal Polyposis | Emthexate Prednol Mometasone Furo... | 18 Years - 75 Years | Dokuz Eylul University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
